Financials PT Kimia Farma Tbk

Equities

KAEF

ID1000070303

Drug Retailers

End-of-day quote INDONESIA S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
735 IDR -1.34% Intraday chart for PT Kimia Farma Tbk +0.68% -49.13%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 14,995,800 14,440,400 6,942,500 23,604,500 13,496,220 6,026,090
Enterprise Value (EV) 1 16,025,672 16,519,990 13,878,890 30,115,451 20,771,679 11,986,304
P/E ratio 45.9 x 34.7 x -546 x 1,338 x 44.6 x -35.4 x
Yield - - - 0.03% - -
Capitalization / Revenue 2.45 x 1.94 x 0.74 x 2.36 x 1.05 x 0.63 x
EV / Revenue 2.62 x 2.22 x 1.48 x 3.01 x 1.62 x 1.25 x
EV / EBITDA 29.1 x 20.8 x 24.4 x 37.7 x 17.1 x 13.2 x
EV / FCF -18.5 x -16.1 x -5.61 x 34.9 x -17.8 x -22 x
FCF Yield -5.41% -6.2% -17.8% 2.86% -5.62% -4.54%
Price to Book 5.97 x 4.51 x 0.96 x 3.38 x 1.89 x 0.76 x
Nbr of stocks (in thousands) 5,554,000 5,554,000 5,554,000 5,554,000 5,554,000 5,554,000
Reference price 2 2,700 2,600 1,250 4,250 2,430 1,085
Announcement Date 3/28/18 4/2/19 3/27/20 3/31/21 3/31/22 4/1/23
1IDR in Million2IDR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 6,127,479 7,454,115 9,400,535 10,006,173 12,857,627 9,606,145
EBITDA 1 550,139 795,157 567,697 799,644 1,214,604 908,821
EBIT 1 486,400 692,137 410,181 636,298 969,247 534,638
Operating Margin 7.94% 9.29% 4.36% 6.36% 7.54% 5.57%
Earnings before Tax (EBT) 1 449,710 577,726 38,315 73,359 392,883 49,622
Net income 1 326,786 415,896 -12,724 17,639 302,274 -170,045
Net margin 5.33% 5.58% -0.14% 0.18% 2.35% -1.77%
EPS 2 58.84 74.88 -2.291 3.176 54.42 -30.62
Free Cash Flow 1 -867,144 -1,024,930 -2,472,297 861,885 -1,167,329 -543,663
FCF margin -14.15% -13.75% -26.3% 8.61% -9.08% -5.66%
FCF Conversion (EBITDA) - - - 107.78% - -
FCF Conversion (Net income) - - - 4,886.29% - -
Dividend per Share - - - 1.270 - -
Announcement Date 3/28/18 4/2/19 3/27/20 3/31/21 3/31/22 4/1/23
1IDR in Million2IDR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 1,029,872 2,079,590 6,936,390 6,510,951 7,275,459 5,960,214
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.872 x 2.615 x 12.22 x 8.142 x 5.99 x 6.558 x
Free Cash Flow 1 -867,144 -1,024,930 -2,472,297 861,885 -1,167,329 -543,663
ROE (net income / shareholders' equity) 13.7% 13.6% 0.27% 0.28% 4.04% -1.14%
ROA (Net income/ Total Assets) 5.68% 5.56% 1.73% 2.21% 3.43% 1.75%
Assets 1 5,755,711 7,478,257 -736,641 796,515 8,812,899 -9,698,023
Book Value Per Share 2 452.0 577.0 1,304 1,259 1,285 1,435
Cash Flow per Share 2 178.0 353.0 245.0 225.0 135.0 388.0
Capex 1 751,823 1,010,690 774,407 544,486 650,761 593,351
Capex / Sales 12.27% 13.56% 8.24% 5.44% 5.06% 6.18%
Announcement Date 3/28/18 4/2/19 3/27/20 3/31/21 3/31/22 4/1/23
1IDR in Million2IDR
Estimates
  1. Stock Market
  2. Equities
  3. KAEF Stock
  4. Financials PT Kimia Farma Tbk